Blackstone Inc’s GeneDx Holdings Warrant WGSWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-709,509
Closed -$14.2K 177
2022
Q4
$14.2K Hold
709,509
﹤0.01% 172
2022
Q3
$154K Hold
709,509
﹤0.01% 199
2022
Q2
$231K Hold
709,509
﹤0.01% 214
2022
Q1
$490K Hold
709,509
﹤0.01% 193
2021
Q4
$695K Hold
709,509
﹤0.01% 335
2021
Q3
$1.5M Hold
709,509
﹤0.01% 353
2021
Q2
$3.26M Hold
709,509
0.01% 300
2021
Q1
$3.67M Buy
709,509
+184,745
+35% +$1.03M 0.01% 259
2020
Q4
$1.43M Buy
+524,764
New +$1.32M 0.01% 193

Other funds holding WGSWW

Blackstone Inc's WGSWW Position: Q1 2023 in Review

Blackstone Inc sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2023, closing a stake of 709,509 shares — an estimated $14.2K sold.

Blackstone Inc first reported a position in WGSWW in Q4 2020 and held it in 9 quarters. The position peaked at $3.67M in Q1 2021. 21 funds tracked by Wall St. Rank hold WGSWW as of Q1 2023.

  • Blackstone Inc reported no remaining GeneDx Holdings Warrant position as of Q1 2023 after selling out during the quarter.
  • Blackstone Inc sold 709,509 GeneDx Holdings Warrant shares in Q1 2023, an estimated $14.2K.
  • Blackstone Inc first reported a position in GeneDx Holdings Warrant in Q4 2020 and held it in 9 quarters.
  • Blackstone Inc's GeneDx Holdings Warrant position peaked at $3.67M in Q1 2021.
  • 21 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2023.

Based on Blackstone Inc's 13F filing for Q1 2023, filed 15 May 2023.